Results 31 to 40 of about 13,691 (227)
A global bibliometric and visualized analysis of the status and trends of gastroparesis research
European Journal of Medical Research, 2023 Background Gastroparesis has a substantial impact on the quality of life but has limited treatment options, which makes it a public health concern. No bibliometric studies on gastroparesis have been published thus far.
Meng Li +4 more
doaj +1 more source
Movement Disorders Clinical Practice, EarlyView.Abstract Background Levodopa–entacapone–carbidopa intestinal gel (LECIG) was introduced in 2018 as a device‐aided therapy for advanced Parkinson's disease (PD). Objectives The ELEGANCE study (NCT05043103) is gathering real‐world data on long‐term efficacy, safety and patient‐reported outcomes with LECIG from 13 European countries.
Daniel Weiss +10 more
wiley +1 more source
Treatment of gastroparesis with botulinum toxin in patient after allogenic bone marrow transplantation [PDF]
Терапевтический архив, 2018 The case report of botulinum toxin treatment of gastroparesis in a patient following allogenic bone marrow transplantation is described. The causes of gastroparesis and methods of prevention and treatment are discussed.
G M Galstyan +6 more
doaj +3 more sources
Endocrine Reviews, 2019 AbstractThis review covers the epidemiology, pathophysiology, clinical features, diagnosis, and management of diabetic gastroparesis, and more broadly diabetic gastroenteropathy, which encompasses all the gastrointestinal manifestations of diabetes mellitus.
Adil E Bharucha +2 more
openaire +2 more sources
United European Gastroenterology Journal, EarlyView.ABSTRACT Background The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) pandemic has highlighted the potential exacerbation of gastrointestinal symptoms in patients with disorders of gut‐brain interaction (DGBIs). However, the distinct symptom trajectories and psychological burden in patients with post‐COVID‐19 DGBIs compared with patients
Giovanni Marasco +68 more
wiley +1 more source
Electronic Physician, 2018 Background: Gastroparesis is a recognized problem of type 1 and 2 diabetes mellitus that is defined by delayed gastric emptying. Due to insufficient satisfaction of current treatments, the use of complementary and alternative medicine in this field ...
Fatemeh Mahjoub +5 more
doaj +1 more source
United European Gastroenterology Journal, EarlyView.ABSTRACT Malabsorption is a complex and multifaceted condition characterised by the defective passage of nutrients into the blood and lymphatic streams. Several congenital or acquired disorders may cause either selective or global malabsorption in both children and adults, such as cystic fibrosis, exocrine pancreatic insufficiency (EPI), coeliac ...
Marco Vincenzo Lenti +29 more
wiley +1 more source
British Medical Bulletin, 2013 Diabetic gastroparesis (DGP) is a gastric complication of diabetes mellitus that causes nausea, vomiting, early satiety, bloating and abdominal pain, in addition to significant morbidity.Original and review articles were reviewed through PubMed, including relevant guidelines from the European and American Neurogastroenterology Societies.Diagnosis of ...
Christophe, Vanormelingen +2 more
openaire +2 more sources
Journal of the Formosan Medical Association, 2022 Background/Purpose: Gastroparesis is a common but easily overlooked disease. Gastric peroral endoscopic myotomy (G-POEM) is one of the third-space endoscopy techniques to treat gastroparesis. In this study, we aimed to evaluate the efficacy and safety of
Chen-Shuan Chung +9 more
doaj
Gut and Liver, 2020 Background/Aims: Ghrelin agonists are emerging prokinetic agents for treating gastroparesis. Although recent clinical trials have demonstrated their efficacy in patients with diabetic gastroparesis (DG), the impact of such agents on symptoms and gastric ...
Seung Wook Hong +9 more
doaj +1 more source